Clinical Trial Update: Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

View source ↗

Summary

A clinical trial update for the KarXT combination (Xanomeline and Trospium Chloride) evaluating effectiveness and adverse-effect switching in schizophrenia; rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• KarXT (xanomeline-trospium)
• TROSPIUM CHLORIDE
• Xanomeline (Xanomeline)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Schizophrenia | Status: RECRUITING